Certain barriers to uptake of long-acting ART, such as good ad- herence to current regimens and aversion to injections, may contribute to continued demand for daily oral tablets among patients with HIV, according to findings...
B/F/TAF was not inferior to DTG+F/TDF in inhibiting HIV RNA replication while demonstrating superior efficacy for inhibiting HBV DNA replication. The co-occurrence of HIV and HBV infection poses a significant global...